Product code JBF— Hematology
BINAXNOW G6PD TEST
- Classification name
- Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening
- Device class
- Class 2
- Regulation
- 21 CFR 864.7360
- Advisory panel
- Hematology
- Total cleared
- 5
- First cleared
- Most recent
Market context for product code JBF
FDA has cleared devices under product code JBF between 1995 and 2022, filed by 5 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2022
- 2016
- 2008
- 2003
- 1995
Top applicants under product code JBF
Recent clearances under product code JBF
Data sourced from openFDA. This site is unofficial and independent of the FDA.